ArriVent BioPharma, Inc. (AVBP) has 4 open-market insider trades by 3 insiders since 2024. The most active filer is HHLR Advisors, Ltd., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd. | 10% Owner | — | 2 | $23.0M | 2025-12-10 |
| James Healy | Dir | — | 1 | $8.0M | 2024-01-30 |
| Carl L. Gordon | Dir10% Owner | — | 1 | $4.0M | 2024-01-30 |
| OrbiMed Asia GP IV, L.P. via Carl L. Gordon | Dir10% Owner | — | 0 | — | 2024-01-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| HHLR Advisors, Ltd. | 10% | Sell | $13.0M | 2025-12-10 |
| Carl L. Gordon | Director & 10% Owner | Buy | $4.0M | 2024-01-30 |
| James Healy | Director | Buy | $8.0M | 2024-01-30 |
| HHLR Advisors, Ltd. | 10% Owner | Buy | $10.0M | 2024-01-30 |
Companies that share insiders with AVBP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.